|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Takahashi T, Saikawa Y and Kitagawa Y:
Gastric cancer: Current status of diagnosis and treatment. Cancers.
5:48–63. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ajani JA, Bentrem DJ, Besh S, D'Amico TA,
Das P, Denlinger C, Fakih MG, Fuchs CS, Gerdes H, Glasgow RE, et al
National Comprehensive Cancer Network: Gastric cancer, version
2.2013: Featured updates to the NCCN Guidelines. J Natl Compr Canc
Netw. 11:531–546. 2013.PubMed/NCBI
|
|
4
|
Zheng L, Wang L, Ajani J and Xie K:
Molecular basis of gastric cancer development and progression.
Gastric Cancer. 7:61–77. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tamura G, Yin J, Wang S, Fleisher AS, Zou
T, Abraham JM, Kong D, Smolinski KN, Wilson KT, James SP, et al:
E-Cadherin gene promoter hypermethylation in primary human gastric
carcinomas. J Natl Cancer Inst. 92:569–573. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Maekita T, Nakazawa K, Mihara M, Nakajima
T, Yanaoka K, Iguchi M, Arii K, Kaneda A, Tsukamoto T, Tatematsu M,
et al: High levels of aberrant DNA methylation in Helicobacter
pylori- infected gastric mucosae and its possible association with
gastric cancer risk. Clin Cancer Res. 12:989–995. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Niwa T, Tsukamoto T, Toyoda T, Mori A,
Tanaka H, Maekita T, Ichinose M, Tatematsu M and Ushijima T:
Inflammatory processes triggered by Helicobacter pylori infection
cause aberrant DNA methylation in gastric epithelial cells. Cancer
Res. 70:1430–1440. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
El-Omar EM, Carrington M, Chow WH, McColl
KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N,
et al: Interleukin-1 polymorphisms associated with increased risk
of gastric cancer. Nature. 404:398–402. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
He C, Tu H, Sun L, Xu Q, Gong Y, Jing J,
Dong N and Yuan Y: SNP interactions of Helicobacter pylori-related
host genes PGC, PTPN11, IL1B, and TLR4 in susceptibility to gastric
carcinogenesis. Oncotarget. 6:19017–19026. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang TT, Ping YH, Wang AM, Ke CC, Fang
WL, Huang KH, Lee HC, Chi CW and Yeh TS: The reciprocal regulation
loop of Notch2 pathway and miR-23b in controlling gastric
carcinogenesis. Oncotarget. 6:18012–18026. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shen J, Xiao Z, Wu WK, Wang MH, To KF,
Chen Y, Yang W, Li MS, Shin VY, Tong JH, et al: Epigenetic
silencing of miR-490-3p reactivates the chromatin remodeler SMARCD1
to promote Helicobacter pylori-induced gastric carcinogenesis.
Cancer Res. 75:754–765. 2015. View Article : Google Scholar
|
|
12
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Flynn RA and Chang HY: Long noncoding RNAs
in cell-fate programming and reprogramming. Cell Stem Cell.
14:752–761. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huarte M and Rinn JL: Large non-coding
RNAs: Missing links in cancer? Hum Mol Genet. 19:R152–R161. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Prensner JR, Iyer MK, Balbin OA,
Dhanasekaran SM, Cao Q, Brenner JC, Laxman B, Asangani IA, Grasso
CS, Kominsky HD, et al: Transcriptome sequencing across a prostate
cancer cohort identifies PCAT-1, an unannotated lincRNA implicated
in disease progression. Nat Biotechnol. 29:742–749. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Braconi C, Valeri N, Kogure T, Gasparini
P, Huang N, Nuovo GJ, Terracciano L, Croce CM and Patel T:
Expression and functional role of a transcribed noncoding RNA with
an ultraconserved element in hepatocellular carcinoma. Proc Natl
Acad Sci USA. 108:786–791. 2011. View Article : Google Scholar :
|
|
17
|
Pantoja C, de Los Ríos L, Matheu A,
Antequera F and Serrano M: Inactivation of imprinted genes induced
by cellular stress and tumorigenesis. Cancer Res. 65:26–33.
2005.PubMed/NCBI
|
|
18
|
Yap KL, Li S, Muñoz-Cabello AM, Raguz S,
Zeng L, Mujtaba S, Gil J, Walsh MJ and Zhou MM: Molecular interplay
of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by
polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell.
38:662–674. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Brown CJ, Ballabio A, Rupert JL,
Lafreniere RG, Grompe M, Tonlorenzi R and Willard HF: A gene from
the region of the human X inactivation centre is expressed
exclusively from the inactive X chromosome. Nature. 349:38–44.
1991. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bartolomei MS, Zemel S and Tilghman SM:
Parental imprinting of the mouse H19 gene. Nature. 351:153–155.
1991. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rinn JL, Kertesz M, Wang JK, Squazzo SL,
Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E, et
al: Functional demarcation of active and silent chromatin domains
in human HOX loci by noncoding RNAs. Cell. 129:1311–1323. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hou P, Zhao Y, Li Z, Yao R, Ma M, Gao Y,
Zhao L, Zhang Y, Huang B and Lu J: LincRNA-ROR induces
epithelial-to-mesen-chymal transition and contributes to breast
cancer tumorigenesis and metastasis. Cell Death Dis. 5:e12872014.
View Article : Google Scholar
|
|
23
|
Zhang H, Diab A, Fan H, Mani SK, Hullinger
R, Merle P and Andrisani O: PLK1 and HOTAIR accelerate proteasomal
degradation of SUZ12 and ZNF198 during hepatitis B virus-induced
liver carcinogenesis. Cancer Res. 75:2363–2374. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fan J, Xing Y, Wen X, Jia R, Ni H, He J,
Ding X, Pan H, Qian G, Ge S, et al: Long non-coding RNA ROR decoys
gene-specific histone methylation to promote tumorigenesis. Genome
Biol. 16:1392015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Barnhill LM, Williams RT, Cohen O, Kim Y,
Batova A, Mielke JA, Messer K, Pu M, Bao L, Yu AL, et al: High
expression of CAI2, a 9p21-embedded long noncoding RNA, contributes
to advanced-stage neuroblastoma. Cancer Res. 74:3753–3763. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hu Y, Wang J, Qian J, Kong X, Tang J, Wang
Y, Chen H, Hong J, Zou W, Chen Y, et al: Long noncoding RNA GAPLINC
regulates CD44-dependent cell invasiveness and associates with poor
prognosis of gastric cancer. Cancer Res. 74:6890–6902. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang X, Gejman R, Mahta A, Zhong Y, Rice
KA, Zhou Y, Cheunsuchon P, Louis DN and Klibanski A: Maternally
expressed gene 3, an imprinted noncoding RNA gene, is associated
with meningioma pathogenesis and progression. Cancer Res.
70:2350–2358. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang KC, Yang YW, Liu B, Sanyal A,
Corces-Zimmerman R, Chen Y, Lajoie BR, Protacio A, Flynn RA, Gupta
RA, et al: A long noncoding RNA maintains active chromatin to
coordinate homeotic gene expression. Nature. 472:120–124. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Quagliata L, Matter MS, Piscuoglio S,
Arabi L, Ruiz C, Procino A, Kovac M, Moretti F, Makowska Z,
Boldanova T, et al: Long noncoding RNA HOTTIP/HOXA13 expression is
associated with disease progression and predicts outcome in
hepatocellular carcinoma patients. Hepatology. 59:911–923. 2014.
View Article : Google Scholar :
|
|
30
|
Li Z, Zhao X, Zhou Y, Liu Y, Zhou Q, Ye H,
Wang Y, Zeng J, Song Y, Gao W, et al: The long non-coding RNA
HOTTIP promotes progression and gemcitabine resistance by
regulating HOXA13 in pancreatic cancer. J Transl Med. 13:842015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cheng Y, Jutooru I, Chadalapaka G, Corton
JC and Safe S: The long non-coding RNA HOTTIP enhances pancreatic
cancer cell proliferation, survival and migration. Oncotarget.
6:10840–10852. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Deng HP, Chen L, Fan T, Zhang B, Xu Y and
Geng Q: Long non-coding RNA HOTTIP promotes tumor growth and
inhibits cell apoptosis in lung cancer. Cell Mol Biol. 61:34–40.
2015.PubMed/NCBI
|
|
33
|
Zhang H, Zhao L, Wang YX, Xi M, Liu SL and
Luo LL: Long non-coding RNA HOTTIP is correlated with progression
and prognosis in tongue squamous cell carcinoma. Tumour Biol.
36:8805–8809. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Maamar H, Cabili MN, Rinn J and Raj A:
linc-HOXA1 is a noncoding RNA that represses Hoxa1 transcription in
cis. Genes Dev. 27:1260–1271. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang EB, Yin DD, Sun M, Kong R, Liu XH,
You LH, Han L, Xia R, Wang KM, Yang JS, et al: P53-regulated long
non-coding RNA TUG1 affects cell proliferation in human non-small
cell lung cancer, partly through epigenetically regulating HOXB7
expression. Cell Death Dis. 5:e12432014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang X, Lian Z, Padden C, Gerstein MB,
Rozowsky J, Snyder M, Gingeras TR, Kapranov P, Weissman SM and
Newburger PE: A myelopoiesis-associated regulatory intergenic
noncoding RNA transcript within the human HOXA cluster. Blood.
113:2526–2534. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tsai MC, Manor O, Wan Y, Mosammaparast N,
Wang JK, Lan F, Shi Y, Segal E and Chang HY: Long noncoding RNA as
modular scaffold of histone modification complexes. Science.
329:689–693. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liao WT, Jiang D, Yuan J, Cui YM, Shi XW,
Chen CM, Bian XW, Deng YJ and Ding YQ: HOXB7 as a prognostic factor
and mediator of colorectal cancer progression. Clin Cancer Res.
17:3569–3578. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cantile M, Pettinato G, Procino A,
Feliciello I, Cindolo L and Cillo C: In vivo expression of the
whole HOX gene network in human breast cancer. Eur J Cancer.
39:257–264. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Waltregny D, Alami Y, Clausse N, de Leval
J and Castronovo V: Overexpression of the homeobox gene HOXC 8 in
human prostate cancer correlates with loss of tumor
differentiation. Prostate. 50:162–169. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Costa BM, Smith JS, Chen Y, Chen J,
Phillips HS, Aldape KD, Zardo G, Nigro J, James CD, Fridlyand J, et
al: Reversing HOXA9 oncogene activation by PI3K inhibition:
Epigenetic mechanism and prognostic significance in human
glioblastoma. Cancer Res. 70:453–462. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Buske C, Feuring-Buske M, Abramovich C,
Spiekermann K, Eaves CJ, Coulombel L, Sauvageau G, Hogge DE and
Humphries RK: Deregulated expression of HOXB4 enhances the
primitive growth activity of human hematopoietic cells. Blood.
100:862–868. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gu ZD, Shen LY, Wang H, Chen XM, Li Y,
Ning T and Chen KN: HOXA13 promotes cancer cell growth and predicts
poor survival of patients with esophageal squamous cell carcinoma.
Cancer Res. 69:4969–4973. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Duan R, Han L, Wang Q, Wei J, Chen L,
Zhang J, Kang C and Wang L: HOXA13 is a potential GBM diagnostic
marker and promotes glioma invasion by activating the Wnt and TGF-β
pathways. Oncotarget. 6:27778–27793. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Han Y, Tu WW, Wen YG, Li DP, Qiu GQ, Tang
HM, Peng ZH and Zhou CZ: Identification and validation that
up-expression of HOXA13 is a novel independent prognostic marker of
a worse outcome in gastric cancer based on immunohistochemistry.
Med Oncol. 30:5642013. View Article : Google Scholar : PubMed/NCBI
|
